Advertisement

Picture EBD Group Biotech Showcase 2023 San Francisco 650x100px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 4947 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 13 14 15 ... 48 49 50  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Immune Regulation–Metellus: investment, 202009– financing round Series B totalling £40.6m incl co-investor Metellus AG 2020-09-21
Immune Regulation–SEVERAL: investment, 202009– financing round Series B £40.6m in two tranches + incl £6m advance subscription funds 2020-09-21
Inflazome–Byrne Wallace: legal services, 202009 supply service Byrne Wallace is legal advisor with regard to acquisition of Inflazome by Roche 2020-09-21
Inflazome–Goodwin Procter: legal services, 202009 supply service Goodwin Procter is legal advisor with regard to acquisition of Inflazome by Roche 2020-09-21
Inflazome–Lazard: financial services, 202009 supply service Lazard financial advisor with regard to acquisition of Inflazome by Roche 2020-09-21
Inflazome–Roche: investment, 202009 acquisition of Inflazome by Roche for €380m upfront + milestones 2020-09-21
Infarm–SEVERAL: investment, 202009 financing round Series C first closing $170m led by LGT Lightstone 2020-09-17
Lava Therapeutics–Bellevue: investment, 202009 financing round Series C totalling $83m incl new + co-investor BB Pureos Bioventures 2020-09-17
Lava Therapeutics–SEVERAL: investment, 202009 financing round Series C $83m co-led by Novo Ventures + Sanofi Ventures 2020-09-17
Novartis–BioNTech: investment, 202009– acquisition of Novartis GMP Biologics Manufacturing Site in Marburg by BioNTech 2020-09-17
Dinaqor–KWM Communications: public relations, 202009 service existent by KWM Communications 2020-09-16
Maetrics–Regulatory and Quality Solutions: investment, 202009 acquisition of Maetrics by R&Q 2020-09-16
Moderna–Cabinet Privé de Conseils: public relations, 202009 service existent CPC is Swiss media contact 2020-09-16
ImCheck Therapeutics–Bellevue: investment, 202009 financing round Series B extension €6m from BB Pureos Bioventures bringing total Series B to €54m 2020-09-15
Evotec–BIOASTER: antiinfectives, 202009– collab research to establish tech + innovation hub in Lyon work started in early 2020 2020-09-14
Boehringer–Click Therapeutics: digital therapeutics, 202009– collab ufpront+milestones >$500m + royalties ww dev+marketing CT-155 for schizophrenia 2020-09-11
Canopy Biosciences–Bruker: investment, 202009 acquisition €na of Canopy Biosciences LLC by Bruker Corp 2020-09-11
Sumitomo–Gain Therapeutics: small-molecule drugs, 202009– collab strategic RnD targeting allosteric sites in lysosomal enzymes using SEE-Tx 2020-09-10
Bayer–Recursion Pharmaceuticals: AI-based drug discovery, 202009– strategic collab to discover + develop small-molecules for fibrotic diseases 2020-09-09
Oncomfort–SEVERAL: investment, 202009 financing round Series A €10m co-led by Debiopharm + Crédit Mutuel Innovation 2020-09-09
Recursion Pharmaceuticals–Bayer: investment, 202009 financing round Series D totalling $239m incl $50m from new + lead investor Leaps by Bayer 2020-09-09
Recursion Pharmaceuticals–SEVERAL: investment, 202009 financing round Series D $239m led by Leaps by Bayer 2020-09-09
United States (govt)–Valneva: Japanese encephalitis vaccine, 202009–202308 supply $61m + option for up to $105m of Ixiaro to US DoD 2020-09-09
Imcyse–MC Services: public relations, 202009 service existent by MC Services 2020-09-07
Boehringer–BiomX: biomarker discovery, 202009– collab discovery of microbiome-based biomarkers for IBD using XMarker platform 2020-09-02
Evotec–Univ Oxford: biobanking, 202009– collab €na granting Evotec access to QUOD biobank for multi-omics analyses for drug discovery 2020-09-02
BioVersys–SEVERAL: investment, 202009 financing round Series B CHF19m 2020-09-01
Helmholtz–Bruker: NMR spectrometer, 202009c supply 1.2 GHz NMR spectrometer with 28 Tesla to FZ Jülich 2020-09-01
Lobsor–Stada: investment, 202009 acquisition of Lobsor Pharmaceuticals AB by Stada/Britannia 2020-09-01
Switzerland (govt)–Moderna: mRNA-based vaccines, 202009c– contract for supply of 4.5m doses of Covid-19 vaccine candidate mRNA-1273 2020-09-01
Aimmune Therapeutics–Nestlé: investment, 202008– cash tender offer for all remaining shares at $34.5/share representing total equity value of $2.6b 2020-08-31
Semalytix–btov Partners: investment, 202008 financing round Series A totalling €4.3m incl co-lead investor btov 2020-08-31
Semalytix–Fly Ventures: investment, 202008 financing round Series A totalling €4.3m incl existing sedd + co-lead investor Fly Ventures 2020-08-31
Semalytix–SEVERAL: investment, 202008 financing round Series A €4.3m co-led by btov + Fly Ventures 2020-08-31
Aignostics–Berlin (govt): investment, 202008 seed financing round totalling €5m incl co-investor VC Fonds Technologie der IBB 2020-08-28
Aignostics–Boehringer: investment, 202008 seed financing round totalling €5m incl lead investor BIVF 2020-08-28
Aignostics–Hessen (govt): investment, 202008 seed financing round totalling €5m incl co-investor Future Capital 2020-08-28
Aignostics–High-Tech Gründerfonds: investment, 202008 seed financing round totalling €5m incl co-investor HTGF 2020-08-28
Aignostics–SEVERAL: investment, 202008 seed financing round €5m led by BIVF + incl HTGF + IBB VC Fonds Technologie + Future Capital 2020-08-28
Triumvira Immunologics–Bayer: investment, 202008 financing round Series A totalling $55m incl new + co-lead investor Leaps by Bayer 2020-08-27
Triumvira Immunologics–SEVERAL: investment, 202008 financing round Series A $55m co-led by Leaps by Bayer + Northpond Ventures 2020-08-27
Freenome–SEVERAL: investment, 202008 financing round Series C $270m co-led by Bain Capital Life Sciences + Perceptive Advisors 2020-08-26
Univ Guelph–Bruker: NMR spectrometer, 202008 supply existent of 400 MHz NMR spectrometer + Fourier 80 benchtop NRM system 2020-08-24
Scienion–Cellink: investment, 202008– acquisition €80m on cash/debt-free basis with €40m in shares + €40m in shares 2020-08-19
CureVac–Hopp Group: investment, 202008 private placement €100m at $16/share to DH-LT-Investments GmbH + affiliates 2020-08-18
Bayer–Hua Medicine: dorzagliatin, 202008– commercialisation agreement + strategic partnership in China 2020-08-17
Seres Therapeutics–Nestlé: investment, 202008 registered direct offering $20.62m with 959k common stock at $21.5/share to Société des Produits Nestlé 2020-08-17
Seres Therapeutics–SEVERAL: investment, 202008 public offering $225.75m+$33.86m with 10.5m+1.575m shares common stock at $21.5/share 2020-08-17
F2G Ltd–Advent Life Sciences: investment, 202008 financing round totalling $60.8m incl exisiting investor Advent Life Sciences 2020-08-12
F2G Ltd–Cowen: investment, 202008 financing round totalling $60.8m incl new investor Cowen Healthcare Investments 2020-08-12
F2G Ltd–EMS (BR): investment, 202008 financing round totalling $60.8m incl exisiting investor Brace Pharma Capital 2020-08-12
F2G Ltd–Morningside: investment, 202008 financing round totalling $60.8m incl exisiting investor Morningside Ventures 2020-08-12
F2G Ltd–Novo Group: investment, 202008 financing round totalling $60.8m incl exisiting investor Novo Ventures 2020-08-12
F2G Ltd–SEVERAL: investment, 202008 financing round $60.8m from new investor Cowen Healthcare Investments + existing investors 2020-08-12
Atriva Therapeutics–High-Tech Gründerfonds: credit, 202008– convertible loan financing round totalling €8.6m incl existing + co-lead investor HTGF 2020-08-11
Atriva Therapeutics–Meneldor: credit, 202008– convertible loan financing round totalling €8.6m incl existing + co-lead investor Meneldor BV 2020-08-11
Atriva Therapeutics–SEVERAL: credit, 202008– convertible loan financing round €8.6m led by existing investors Meneldor + HTGF 2020-08-11
Bayer–Atomwise: AI-based drug discovery, 202008 collab existent 2020-08-11
Bayer–Linklaters: legal services, 202008 supply service legal counsel with regard to acquisition of Kandy Therapeutics by Bayer 2020-08-11
Bayer–Morgan Stanley: financial services, 202008 supply service financial advisor with regard to acquisition of Kandy Therapeutics by Bayer 2020-08-11
Kandy Therapeutics–Bayer: investment, 202008–202009 acquisition $425m upfront + $450m developm milestones + triple digit $m sales milestones 2020-08-11
Kandy Therapeutics–Goldman Sachs: financial services, 202008 supply service financial advisor with regard to acquisition of Kandy Tx by Bayer 2020-08-11
Kandy Therapeutics–Goodwin Procter: legal services, 202008 supply service legal counsel with regard to acquisition of Kandy Therapeutics by Bayer 2020-08-11
CureVac–SEVERAL: investment, 202008 IPO $245.3m with 13.3m+2m common shares at $16/share at Nasdaq Global Market 2020-08-10
Immunic–SEVERAL: investment, 202008 underwritten public offering $90m+$13.5m with 5m+750k shares common stock at $18/share 2020-08-10
Bruker–Univ Utrecht: mass spectromtery, 202008– collab developm of methods using crosslinkg MS for proteomics with Heck lab 2020-08-07
T-Knife–Andera Partners: investment, 202008 financing round Series A totalling €66m incl existing + co-investor Andera Partners 2020-08-06
T-Knife–Boehringer: investment, 202008 financing round Series A totalling €66m incl existing + co-investor BIVF 2020-08-06
T-Knife–RA Capital: investment, 202008 financing round Series A totalling €66m incl new + co-lead investor RA Capital Management 2020-08-06
T-Knife–SEVERAL: investment, 202008 financing round Series A €66m co-led by Versant Ventures + RA Capital 2020-08-06
T-Knife–Versant Ventures: investment, 202008 financing round Series A totalling €66m incl new + co-lead investor Versant Ventures 2020-08-06
GentiBio–Novartis: investment, 202008 seed financing round totalling $20m inbcl co-lead investor Novartis Venture Fund 2020-08-05
GentiBio–SEVERAL: investment, 202008 seed financing round $20m led by OrbiMed + Novartis Venture + RA Capital Management 2020-08-05
Matterhorn Biosciences–Versant Ventures: investment, 202008– seed financing $30m commitment from Versant Ventures 2020-08-05
NBE Therapeutics–Optimum Strategic Communications: public relations, 202008 service existent by Optimum 2020-08-03
Varian Medical Systems–Siemens: investment, 202008– acquisition $16.4b in cash of Varian Medical Systems Inc by Siemens Healthineers AG ANNOUNCED 2020-08-02
Electrochaea–EU (govt): grant, 202008 Horizon 2020 EIC Accelerator grant €2.5m 2020-08-01
DNA Script–SEVERAL: investment, 202007 financing round Series B extension $50m led by Casdin Capital 2020-07-29
Boehringer–Biognosys: HRM mass spectrometry, 202007– collab using HRM/DIA MS + Spectronaut s/w for drug discovery 2020-07-23
T3 Pharmaceuticals–Boehringer: investment, 202007 3rd financing round totalling CHF25m incl existing investor BIVF 2020-07-22
T3 Pharmaceuticals–OTHER: investment, 202007 3rd financing round totalling CHF25m incl existing private Swiss investors 2020-07-22
T3 Pharmaceuticals–Reference Capital: investment, 202007 3rd financing round totalling CHF25m incl existing investor Reference Capital SA 2020-07-22
T3 Pharmaceuticals–SEVERAL: investment, 202007 3rd financing round CHF25m from existing investors 2020-07-22
T3 Pharmaceuticals–Wille Finance: investment, 202007 3rd financing round totalling CHF25m incl existing investor Wille Finance AG 2020-07-22
Vesigen Therapeutics–Bayer: investment, 202007 financing round Series A totalling $28.5m incl co-lead investor Leaps by Bayer 2020-07-22
Vesigen Therapeutics–SEVERAL: investment, 202007 financing round Series A $28.5m co-led by Leaps by Bayer + Morningside Ventures 2020-07-22
Gain Therapeutics–SEVERAL: investment, 202007 financing round Series B $10m from institutional + accredited investors 2020-07-21
Quantro Therapeutics–Boehringer: investment, 202007 seed financing round from BIVF + Evotec acquiring equal minority stakes 2020-07-21
Quantro Therapeutics–Evotec: drug discovery services, 202007– supply of hit identification services by Evotec 2020-07-21
Quantro Therapeutics–Evotec: investment, 202007 seed financing round from BIVF + Evotec acquiring equal minority stakes 2020-07-21
Quantro Therapeutics–MC Services: public relations, 202007 service existent by MC Services 2020-07-21
Quantro Therapeutics–SEVERAL: investment, 202007 seed financing round from BIVF + Evotec acquiring equal minority stakes 2020-07-21
Tubulis–Bavaria (govt): investment, 202007 financing round Series A totalling €10.7m incl co-investor Bayern Kapital 2020-07-21
Tubulis–BioMedPartners: investment, 202007 financing round Series A totalling €10.7m incl co-lead investor BioMedPartners 2020-07-21
Tubulis–BPCE: investment, 202007 financing round Series A totalling €10.7m incl co-investor Seventure Partners 2020-07-21
Tubulis–Germany (govt): investment, 202007 financing round Series A totalling €10.7m incl co-investor Coparion 2020-07-21
Tubulis–High-Tech Gründerfonds: investment, 202007 financing round Series A totalling €10.7m incl co-lead investor HTGF 2020-07-21
Tubulis–Occident: investment, 202007 financing round Series A totalling €10.7m incl co-investor Occident Group 2020-07-21
Tubulis–SEVERAL: investment, 202007 financing round Series A €10.7m co-led by BioMedPartners + HTGF 2020-07-21
Tubulis–Trophic Communications: public relations, 202007 service existent by Trophic Communications 2020-07-21
next pagenext page 1 2 3 ... 13 14 15 ... 48 49 50  next pagenext page



Advertisement

Picture [iito] No Content Marketing 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Campus Berlin-Buch GmbH BBC BerlinBioCube Start-up Center 650x300px

» top